Authors
Latest:
Richard Gallo, MD, PhD: Updates on Understanding the Pathophysiology of AcneGallo presented pearls on the pathophysiology of acne and how newer studies have changed acne treatment methodologies at AAD 2024.
Latest:
Proper Coding Gets Practices What They Are OwedA physician’s goal is to care for patients, but a key part of being able to provide that care is the eternal quest for payment. One way to ensure that a practice maximizes its coding regimen is to make sure each session can be efficiently billed.
Latest:
Aaron Farberg, MD, Gears Up For Early Career Advice and Melanoma Sessions at Fall ClinicalFarberg is looking forward to another year of top-notch presentations at Fall Clinical 2023.
Latest:
Differences in Anti-PD-1/CTLA-4 and Anti-PD-1/LAG-3 Reported in Recent StudyThe study examined the mechanisms of action associated with immune checkpoint inhibitor combination therapies.
Latest:
Tunlametinib Wins Approval in China for NRAS+ Advanced Melanoma After PD-1/PD-L1 TherapyChina’s NMPA has approved tunlametinib for the treatment of patients with NRAS-mutated advanced melanoma after prior anti–PD-1/PD-L1 therapy.
Latest:
Introducing Omar Noor, MD, FAAD: Dermatology Times' Newest Editorial Advisory Board MemberNoor, the co-owner of Rao Dermatology, shares about his interests in dermatology and what he most looks forward to as a member of our board.
Latest:
Improving Representation of Skin of Color in DermatologyMiranda Uzoma Ewelukwa, MD, FAAD, reviews how skin of color representation has evolved in dermatology, however, more advocacy is still needed.
Latest:
The Adalimumab Biosimiliar Pipeline: What's AheadFDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Latest:
How a digital front door can improve patients’ access to careOnline-first engagement ensures patients obtain the right care for their specific needs.
Latest:
ReV Up Your Vitiligo Treatment StrategiesNanette Silverberg, MD, takes a deep dive into the importance of early intervention and gave an overview of topical care for patients of all ages with vitiligo.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
Sunscreen Protection for ChildrenProtection from the harsh rays of the sun is crucial for everyone—including children. Now that summer has arrived, a refresher course for your patients and their families on sun protection, which can go a long way in preventing skin damage and disorders due to the sun.
Latest:
Pointers With Portela: Minimalist Skin Care RoutinesIn this week’s Pointers With Portela, the 208SkinDoc discusses the effectiveness of a minimalist anti-aging skin care routine for patients.
Latest:
Impact of Data on Generalized Pustular PsoriasisAaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.
Latest:
Jay A. Lieberman, MD, FACAAI: Clinical Pearls and Hands-On Educational Opportunities at ACAAI Annual MeetingProgram Chair Jay A. Lieberman, MD, provides a glimpse into the clinical pearls and dermatological educational opportunities presented at the ACAAI 2023 Annual Scientific Meeting.
Latest:
Hypochlorous Acid: Is It Just a Trend?As someone who practices dermatology, it can often be difficult to determine if any of these new skin care trends are efficacious.
Latest:
Safety and Access Considerations: Topical Ruxolitinib ReviewDr Linda Stein-Gold and Dr Michael Cameron assess the safety and tolerability of topical ruxolitinib cream, offering guidance on counseling patients about the black box warning. They also address the perception of limited treatment access and strategies for overcoming this barrier.
Latest:
Take-Home Pearls on the Management of Plaque PsoriasisAlexa Hetzel, MS, PA-C; Jennifer Conner, MPAS, PA-C; Terry Faleye, MPAS, PA-C; Laura Bush, DMSc, PA-C; and Lakshi Aldredge, MSN, ANP-BC, share take-home messages regarding the treatment of patients with plaque psoriasis, highlighting listening to and educating patients.
Latest:
How Physicians Can Provide Better Care for Patients with Chronic ConditionsTechnology and care navigators are key to managing this growing population
Latest:
Topical Steroid Withdrawal Syndrome Manifesting in Patients Treated for Atopic DermatitisRecent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.
Latest:
Do You Have the Right Financial Adviser?Experts detail 5 tips to ask a financial advisor so they can best serve your interests.
Latest:
Enhancing Accessibility: Ruxolitinib Cream and Improved Patient AccessLisa Swanson, MD, FAAD, sheds light on the enhanced accessibility of ruxolitinib cream, highlighting its improved availability for patients in need.
Latest:
Exploring the Diagnostics of Urticaria at ACAAISession at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting explored issues in understanding and testing for physical urticaria.
Latest:
Kim Papp, MD, PhD, FRCPC: Exploring the Potential of ESK-001 in Plaque PsoriasisPapp shared insights from the recent STRIDE phase 2 trial, which met all its primary and secondary endpoints. Data was presented at the American Academy of Dermatology Annual Meeting.
Latest:
Case 2: Male, 23 Years OldAn expert in dermatology presents the case of a 23-year-old male patient presenting with unstable vitiligo. He delves into treatment options available for managing this condition, shedding light on the nuances and optimal scenarios for each therapeutic agent.
